Association Between Vitamin D Deficiency and Preeclampsia: A Case Control Study

To find out if lower levels of vitamin D is more prevalent in preeclamptic women

Completed

Looking for future studies?

Key information

Conditions

Pre-eclampsia Female Urogenital Diseases and Pregnancy Complications Hypertension, Pregnancy-Induced Pregnancy Complications Urogenital Diseases

Age range

18 year–35 year

Sex eligibility

Female

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Parity: primigravida.
Age: 18 - 35 years.
Singleton pregnancy.
Gestational age: 36-40 weeks.
No past history of any medical disorder and with no other medical complications during pregnancy

Exclusion criteria

Women with preexisting medical conditions like rheumatoid arthritis, thyroid, hepatic or renal failure, metabolic bone disease, diabetes mellitus, malabsorption and lupus.
History of intake of medications influencing bone, vitamin D or calcium metabolism e.g. antiepileptic, theophylline, antitubercular drugs in the last 6 months.
Women with multiple pregnancy.
Women with congenital fetal malformation.
Women with known thrombophilia

Treatment and study plan

Primary outcomes

vitamin D level in preeclamptic and non preeclamptic women

Time frame: six months

Sponsors and collaborators

Lead sponsor

Ain Shams Maternity Hospital

Other

Registry information

Important dates

Study start: 2015
Primary completion: 2015
Study completion: 2016
First posted: Feb 9, 2016
Registry last updated: Feb 9, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed